Yohimbine: Clinical Trials

29 trials of Yohimbine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 4 withdrawn, 2 not yet recruiting, 1 terminated. 9 Phase 2, 7 Not applicable, 4 Phase 1, 3 Early Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 29Completed 6, Withdrawn 2, Not yet recruiting 1
Not applicable7Completed 5, Not yet recruiting 1, Unknown 1
Phase 14Completed 4
Early Phase 13Completed 1, Terminated 1, Withdrawn 1
Phase 43Completed 2, Withdrawn 1
Phase 31Completed 1

Follow Yohimbine: new trials by email Literature Review of Yohimbine trials Research Report on Yohimbine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder
Yohimbine + Hydrocortisone, Active rTMS, Placebo - Opioid Use Disorder
Phase 2Not yet recruitingWayne State University202026-10-012025-12-30
Evaluation of Solanidine as an Exogenous Biomarker to Phenotype CYP2D6 Activity in Humans
Yohimbine, Consumption of a defined potato-rich meal - Pharmacokinetic Study in Healthy Volunteers
Not applicableNot yet recruitingUniversity Medicine Greifswald302026-09-212026-09-14
Kinetics of Yohimbine in Humans to Explore Sex and CYP2D6 Genotype Interactions
Yohimbine, ¹³C₃-caffeine - Pharmacokinetic Study in Healthy Volunteers
Not applicableCompletedUniversity Medicine Greifswald362025-04-282026-01-21
Cannabinoids and Biological Reactivity to Stress
Hydrocortisone Oral, Yohimbine Hydrochloride, Cornstarch Placebo 20mg - Cannabis Use Disorder
Early Phase 1CompletedFlorida State University382024-09-302026-10-22
Role Of Sensitivity to neuroEndocrine Systems in Social Decisions
Hydrocortisone, Yohimbine, Placebo - Borderline Personality Disorder
Phase 4WithdrawnUniversity of North Carolina, Chapel Hill2024-07-012024-06-05
PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention
PROWESS - Prostate Cancer, Prostatic Neoplasms
Not applicableCompletedMassachusetts General Hospital142023-08-282025-10-02
Using rTMS to Explore Neural Mechanisms of Stress-Induced Opioid Use
Placebo oral tablet, Yohimbine + Hydrocortisone, sham rTMS - Stress, Opioid-use Disorder
Phase 2WithdrawnWayne State University2023-04-102023-04-13
rTMS of Limbic Circuitry in Stress Modulation in Healthy Volunteers
yohimbine + hydrocortisone, medial prefrontal cortex rTMS, Placebo oral tablet - Stress, Healthy
Phase 2WithdrawnWayne State University2023-04-102023-04-13
The Role of the Noradrenergic System in the Nonmotor Symptoms of Parkinson's Disease
Yohimbine HCl - Parkinson Disease
Early Phase 1WithdrawnNathaniel M. Robbins2021-05-112023-08-23
The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat
"Yohimbine", "Hydrocortisone", "Yohimbine + Hydrocortisone" - Yohimbine, Hydrocortisone
Not applicableCompletedCharite University, Berlin, Germany1672019-11-012022-03-15
Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension
Yohimbine, Melatonin - Hypotension, Orthostatic, Hypertension
Early Phase 1TerminatedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's102018-03-012019-06-12
Effects of Stress and Drug-cue Exposure (SCM)
Yohimbine - Marijuana Abuse
Phase 1CompletedWayne State University122017-11-012024-04-23
Investigation of Nicotine Seeking Behavior in Current Smokers
Yohimbine Hydrochloride, Hydrocortisone, Lactose Monohydrate Powder - Cigarette Smoking
Phase 1CompletedWayne State University212016-01-072018-09-13
Noradrenergic Activity, Cognition and Major Depressive Disorder
yohimbine, placebo - Major Depressive Disorder, Early Life Trauma
Not applicableCompletedCharite University, Berlin, Germany1312014-06-012019-05-23
Influence of the Noradrenergic System on the Formation of Intrusive Memories
Stress Film, Yohimbine, Clonidine - Intrusive Memories
Not applicableCompletedCharite University, Berlin, Germany1182013-11-012015-09-04
The Role of Sympatho-vagal Balance on Different Limbs of Pain Perception in Healthy Subjects
Yohimbine - Pain
Not applicableUnknownTel-Aviv Sourasky Medical Center202012-08-012012-06-18
Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant
Yohimbine - Type 2 Diabetes
Phase 2CompletedAnders Rosengren, MD PhD502012-05-012015-01-09
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine
Yohimbine, Placebo - Post-Traumatic Stress Disorder
Phase 2CompletedVA Office of Research and Development262010-12-012018-02-07
Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine
Yohimbine - Erectile Dysfunction
Phase 4CompletedWalter Ritter GmbH & Co422009-10-012015-06-26
Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
Group Cognitive Behavioral Therapy, Yohimbine Hydrochloride, Sugar Pill - Social Anxiety Disorder
Phase 3CompletedSouthern Methodist University402009-03-012013-11-11

Showing 20 of 29. Sign in to see all of them.

Conditions studied

Hypotension, Orthostatic (3)  ·  Depressive Disorder, Major (2)  ·  Erectile Dysfunction (2)  ·  Opioid-Related Disorders (2)  ·  Alcoholism (1)  ·  Autonomic Nervous System Diseases (1)  ·  Borderline Personality Disorder (1)  ·  Cigarette Smoking (1)  ·  Cocaine-Related Disorders (1)  ·  Depression (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Fasting (1)  ·  Hypertension (1)  ·  Marijuana Abuse (1)  ·  Mood Disorders (1)

Sponsors

Wayne State University (5)  ·  National Institute of Mental Health (NIMH) (4)  ·  Charite University, Berlin, Germany (3)  ·  University Medicine Greifswald (2)  ·  Anders Rosengren, MD PhD (1)  ·  Florida State University (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Massachusetts General Hospital (1)  ·  Mayo Clinic (1)  ·  Medical University of South Carolina (1)  ·  Medical University of Vienna (1)  ·  Nathaniel M. Robbins (1)  ·  National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1)  ·  Southern Methodist University (1)  ·  Tel-Aviv Sourasky Medical Center (1)

Countries

United States (17)  ·  Germany (6)  ·  Austria (1)  ·  Canada (1)  ·  Israel (1)  ·  Sweden (1)

Top investigators

Adil E Bharucha, MBBS, M.D. (1)  ·  Anders Rosengren, MD PhD (1)  ·  Carlos A Zarate, M.D. (1)  ·  Daniel Lage, MD (1)  ·  Eric A Woodcock, PhD (1)  ·  Frank Donath, MD (1)  ·  Italo Biaggioni, MD (1)  ·  Jasper Smits, Ph.D. (1)  ·  Kathleen T Brady, M.D., Ph.D. (1)  ·  Leslie Lundahl, PhD (1)  ·  Mark Greenwald, PhD (1)  ·  Mark K Greenwald, PhD (1)  ·  Michael N Hallquist, PhD (1)

Results publications

PMID 10662747, PMID 11904109, PMID 11927799, PMID 12119802, PMID 12832331, PMID 15066944, PMID 15710782, PMID 15738343, PMID 17515447, PMID 17515448, PMID 20837887, PMID 21704134, PMID 22311903, PMID 24237691, PMID 25809565, PMID 26654474, PMID 27271310, PMID 38581746, PMID 38902928, PMID 39727053, PMID 9727818

NIH funding

F31DA040369 (1), P50DA016511 (1), R21DA058780 (1)